Achieving Gout Goals in Your Practice
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network (PCN) and Fortis Spectrum. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.
Primary Care Network designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other healthcare professionals will be issued a certificate of participation.
This internet enduring activity will be available for one year, beginning November 30, 2016 through November 30, 2017.
Gout is the most common form of inflammatory arthritis affecting 4% of US adults. In a recent study of more than 13,000 patients with gout, less than one-third (1/3) “ever” achieved target serum urate goals over an extended follow-up period. In short, gout is a problem for patients and straining healthcare systems. Although gout is a problem in primary care, there are paths leading to improved care, better outcomes, and reduced costs.
Dr. Paul Doghramji is a clinician and educator with many years of gout practice experience. Significant research over the past 8-10 years has led to expansion of therapeutic options for treating gout and providing focus to the need for gout-ready practices. To that end, Dr. Doghramji summarizes the new information into useful practice guidance.
After completing this activity, the participant should be better able to:
- Treat patients to goal, achieving uric acid (UA) levels of 6 mg/dL or 5 mg/dL by utilizing appropriate ULT
- Design individualized treatment plans that optimize patient knowledge and response
Jointly provided by Primary Care Network and Fortis Spectrum.
This activity has expired and is no longer available for CME; however, we hope you still enjoy the education.
Published November 30, 2016